PRAME expression in genital melanocytic lesions – Potential diagnostic pitfall of intermediate expression in atypical genital nevi
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Joanna Ka Man Ng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Melanoma, Biomarkers, Tumor, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The Preferentially Expressed Antigen in Melanoma (PRAME) immunostain has seen significant diagnostic use in confirming malignancy for melanocytic lesions. However, the expression of PRAME in genital melanocytic lesions have not been reported. In this study, PRAME staining was performed on a cohort of genital melanocytic lesions, aiming to investigate the diagnostic role of PRAME in genital melanocytic lesions and its expression in atypical genital nevi. METHODOLOGY: A cohort including genital invasive melanoma, melanoma-in-situ, atypical genital nevus (AGN), compound nevus, intradermal nevus, blue nevus, lentigo and melanosis was retrieved with histology reviewed and PRAME immunostaining performed. RESULTS: A total of 66 cases were reviewed. The average proportion expression of PRAME were 56.75 % and 57.43 % for invasive melanoma and melanoma-in-situ, with average H-scores of 153.5/300 and 163.14/300 respectively, which were greater than AGN (3.25 %, 7.75/300, p 100/300); 69.57 % and 95.83 % (>10/300); and 82.61 % and 93.75 % (≥1/300) respectively. Low level PRAME expression was seen in half of the cases of AGN (n=2/4, 50 %), and at low cutoffs (>10/300 and ≥1/300) unable to differentiate invasive melanoma from AGN (p>0.05). CONCLUSIONS: For genital melanocytic lesions, PRAME immunostain shows high specificity at strong and diffuse staining. AGN not uncommonly display low level expression. Focal and/or weak PRAME expression should not be considered as an absolute indication of malignancy, and comprehensive histological assessment remains the key to accurate diagnosis of melanocytic lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
- Department of Pathology, Queen Mary Hospital, School of Clinical Medicine, The University of Hong Kong, Hong Kong. Electronic address: joshuajl@hku.hk.
Zitieren
APA
Ng, J. K. M., Choi, P. C. L., Chow, C., Li, J. J. X., & To, K. F. (2024). PRAME expression in genital melanocytic lesions – Potential diagnostic pitfall of intermediate expression in atypical genital nevi. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155404
Vancouver
Ng JKM, Choi PCL, Chow C, Li JJX, To KF. PRAME expression in genital melanocytic lesions – Potential diagnostic pitfall of intermediate expression in atypical genital nevi. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155404
BibTeX
@article{Ng2024,
author = {Ng, Joanna Ka Man and Choi, Paul Cheung Lung and Chow, Chit and Li, Joshua Jing Xi and To, Ka Fai},
title = {PRAME expression in genital melanocytic lesions – Potential diagnostic pitfall of intermediate expression in atypical genital nevi},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155404}
}
EUVIMED